Literature DB >> 15078345

Juvenile xanthogranuloma associated with neurofibromatosis 1: 14 patients without evidence of hematologic malignancies.

Stefano Cambiaghi1, Lucia Restano, Ruggero Caputo.   

Abstract

The clinical features and natural history of juvenile xanthogranuloma (JXG) in 14 children affected by neurofibromatosis 1 (NF1) are reported. Mean follow-up in 11 of these patients was 4.3 years (range 1-10 years). None of the children developed hematologic malignancies during this period. The onset of JXG was in the first 2 years of life in 13 of the patients. In this series, the association between JXG and six or more café au lait spots more than 5 mm in diameter was a good marker for NF1 in the first few years of life. Overall the JXG in these patients did not show any features distinguishable from those of "classical" JXG.

Entities:  

Mesh:

Year:  2004        PMID: 15078345     DOI: 10.1111/j.0736-8046.2004.21201.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  12 in total

Review 1.  [Histiocytic diseases in childhood and adolescence].

Authors:  C Vokuhl; I Oschlies; W Klapper; I Leuschner
Journal:  Pathologe       Date:  2015-09       Impact factor: 1.011

2.  The child with spontaneous recurrent bleeding in the eye.

Authors:  Aparna Rao; Debanand Padhy
Journal:  BMJ Case Rep       Date:  2014-06-13

3.  Multiple Juvenile Xanthogranuloma of the Eyelids.

Authors:  Hidetsugu Mori; Yuta Nakamichi; Kanji Takahashi
Journal:  Ocul Oncol Pathol       Date:  2017-08-12

Review 4.  Guidelines for the diagnosis and management of individuals with neurofibromatosis 1.

Authors:  Rosalie E Ferner; Susan M Huson; Nick Thomas; Celia Moss; Harry Willshaw; D Gareth Evans; Meena Upadhyaya; Richard Towers; Michael Gleeson; Christine Steiger; Amanda Kirby
Journal:  J Med Genet       Date:  2006-11-14       Impact factor: 6.318

5.  An histologically atypical NF-type 1 patient with a new pathogenic mutation.

Authors:  Giovanni Bianco; Giuseppe Greco; Manila Antonelli; Stefania Casali; Cinzia Castagnini
Journal:  Neurol Sci       Date:  2012-01-06       Impact factor: 3.307

Review 6.  Fatal juvenile xanthogranuloma presenting as a sellar lesion: case report and literature review.

Authors:  Sherise D Ferguson; Steven G Waguespack; Lauren A Langford; Joann L Ater; Ian E McCutcheon
Journal:  Childs Nerv Syst       Date:  2014-12-12       Impact factor: 1.475

Review 7.  [Benign skin neoplasms in children].

Authors:  Carmen Maria Salavastru; Alexandra-Irina Butacu; Klaus Fritz; Seher Eren; George-Sorin Tiplica
Journal:  Hautarzt       Date:  2022-01-14       Impact factor: 0.751

Review 8.  Histiocytic disorders.

Authors:  Kenneth L McClain; Camille Bigenwald; Matthew Collin; Julien Haroche; Rebecca A Marsh; Miriam Merad; Jennifer Picarsic; Karina B Ribeiro; Carl E Allen
Journal:  Nat Rev Dis Primers       Date:  2021-10-07       Impact factor: 65.038

9.  Treatment of neurofibromatosis type 1.

Authors:  Caterina Sabatini; Donatella Milani; Francesca Menni; Gianluca Tadini; Susanna Esposito
Journal:  Curr Treat Options Neurol       Date:  2015-06       Impact factor: 3.598

10.  Juvenile xanthogranuloma in a child with previously unsuspected neurofibromatosis type 1 and juvenile myelomonocytic leukemia.

Authors:  Margarita Raygada; Diane C Arthur; Alan S Wayne; Owen M Rennert; Jeffrey A Toretsky; Constantine A Stratakis
Journal:  Pediatr Blood Cancer       Date:  2010-01       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.